John Mascarenhas, MD, describes his personal experience with using pacritinib to treat patients with myelofibrosis and reviews the study design and outcomes for both the PERSIST-1 and PERSIST-2 trials.
Case: A 76-Year-Old Woman with Myelofibrosis
Initial presentation
Clinical workup
Treatment